Luca Benatti - 23 Oct 2023 Form 3 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact for Luca Benatti
Issuer symbol
QNCX
Transactions as of
23 Oct 2023
Net transactions value
$0
Form type
3
Filing time
24 Oct 2023, 19:43:50 UTC
Previous filing
25 May 2023
Next filing
13 Nov 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QNCX Common Stock 80,261 23 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.